Bristol-Myers to Take a $3B Tax Hit in Q4 2017 Post author:Sam Post published:January 7, 2018 Post category:BioPharma The expense is primarily related to taxes on unremitted offshore earnings, the company said. Source: BioSpace You Might Also Like Genentech Will Pass Out More Cash to Researchers to May 17, 2017 Egalet Cuts Workforce By 40% in Expense Reduction Plan August 9, 2017 Dynavax Secures $175 Million in Funding to Support Launch of Recently Approved Heplisav-B February 19, 2018
Dynavax Secures $175 Million in Funding to Support Launch of Recently Approved Heplisav-B February 19, 2018